Dahlgren, D.;                     Cano-Cebrián, M.-J.;                     Olander, T.;                     Hedeland, M.;                     Sjöblom, M.;                     Lennernäs, H.    
        Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics 2020, 12, 242.
    https://doi.org/10.3390/pharmaceutics12030242
    AMA Style
    
                                Dahlgren D,                                 Cano-Cebrián M-J,                                 Olander T,                                 Hedeland M,                                 Sjöblom M,                                 Lennernäs H.        
                Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics. 2020; 12(3):242.
        https://doi.org/10.3390/pharmaceutics12030242
    
    Chicago/Turabian Style
    
                                Dahlgren, David,                                 Maria-Jose Cano-Cebrián,                                 Tobias Olander,                                 Mikael Hedeland,                                 Markus Sjöblom,                                 and Hans Lennernäs.        
                2020. "Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat" Pharmaceutics 12, no. 3: 242.
        https://doi.org/10.3390/pharmaceutics12030242
    
    APA Style
    
                                Dahlgren, D.,                                 Cano-Cebrián, M.-J.,                                 Olander, T.,                                 Hedeland, M.,                                 Sjöblom, M.,                                 & Lennernäs, H.        
        
        (2020). Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Pharmaceutics, 12(3), 242.
        https://doi.org/10.3390/pharmaceutics12030242